financetom
Business
financetom
/
Business
/
Las Vegas Sands Q3 Adjusted Earnings, Revenue Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Las Vegas Sands Q3 Adjusted Earnings, Revenue Decline
Oct 24, 2024 8:20 AM

04:41 PM EDT, 10/23/2024 (MT Newswires) -- Las Vegas Sands ( LVS ) reported Q3 adjusted earnings late Wednesday of $0.44 per diluted share, down from $0.55 a year earlier.

Analysts surveyed by Capital IQ expected adjusted EPS of $0.53.

Revenue for the quarter ended Sept. 30 was $2.68 billion, down from $2.80 billion a year earlier.

Analysts polled by Capital IQ expected $2.79 billion.

The company said its board raised the annual dividend to $1 per share for 2025, increasing quarterly dividends to $0.25 from $0.20.

Las Vegas Sands ( LVS ) said it repurchased $450 million of its common shares during Q3 and its board authorized $2 billion in share repurchases.

Price: 51.30, Change: +0.26, Percent Change: +0.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amazon projects quarterly revenue below estimates, shares slide
Amazon projects quarterly revenue below estimates, shares slide
Aug 1, 2024
(Reuters) -Amazon.com forecast current quarter sales below estimates, and shares fell sharply after hours even though second-quarter profit beat Wall Street estimates. Amazon's ( AMZN ) focus on successes in its AWS cloud computing did not cheer investors who sent shares of the Seattle-based company down more than 6% in extended trading. We're continuing to make progress on a number...
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments
Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments
Aug 1, 2024
(Reuters) - Vertex Pharmaceuticals ( VRTX ) raised its annual revenue forecast on Thursday, betting on robust demand for its cystic fibrosis (CF) treatments. The drugmaker now expects 2024 product revenue in the range of $10.65 to $10.85 billion, compared to its prior forecast of $10.55 to $10.75 billion. The company said that the forecast includes expectations for continued growth...
MP Materials swings to quarterly loss on sliding prices for rare earths
MP Materials swings to quarterly loss on sliding prices for rare earths
Aug 1, 2024
(Reuters) - U.S. rare earths producer MP Materials ( MP ) said on Thursday it swung to a loss in the second quarter due to falling prices for the strategic minerals and operational challenges. The Las Vegas-based company posted a net loss of $34.1 million, or 21 cents per share, compared to a net profit of $7.4 million, or 9...
--Intel Reports Q2 Revenue of $12.83 Billion vs. Street Estimate of $12.98 Billion
--Intel Reports Q2 Revenue of $12.83 Billion vs. Street Estimate of $12.98 Billion
Aug 1, 2024
04:06 PM EDT, 08/01/2024 (MT Newswires) -- Price: 25.40, Change: -3.65, Percent Change: -12.58 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved